PTC Launches Arena AI Engine to Accelerate Intelligent Automation Across PLM and QMS Workflows

  • Streamlines change management by automating the review and comparison of complex product documents
  • Improves accuracy and consistency across PLM and QMS workflows through AI-driven detection of key changes and compliance-relevant details
  • Enhances product development confidence with stronger security, better visibility into revisions, and more reliable decision support 

PTC (NASDAQ: PTC) today announced the release of its Arena® product lifecycle management (PLM) and quality management system (QMS) AI Engine. Powered by Amazon Bedrock, Arena AI Engine functionality automates document review and comparison to enable teams to reduce errors, strengthen compliance, and work through file changes more quickly.

"Our customers manage complex documentation and ongoing revisions that can slow work and increase risk," said David Katzman, Executive Vice President and General Manager of Onshape and Arena by PTC. "The launch of Arena AI Engine marks the next step in our long-term investment to make those processes more intuitive and give teams greater clarity and control over their product information."

Building on the Arena AI infrastructure, key features of Arena AI Engine include:

  • AI File Summary action to condense lengthy reports into clear, actionable insights, helping teams share concise updates and move approvals along quickly.
  • AI File Comparison action to speed training and change management version control by automatically highlighting changes across specifications, designs, diagrams, and other files to reduce manual checks and compliance risks.

Arena AI Engine extends PTC's Intelligent Product Lifecycle vision by bringing AI-driven intelligence directly into everyday PLM and QMS workflows, enabling teams to make faster, more confident decisions across the product lifecycle.

In addition to the launch of Arena AI Engine, this release strengthens supply chain resiliency through new Arena AI Assistant and Arena Supply Chain Intelligence (SCI) features, including:

  • Enhancements to the Arena AI Assistant to add support with more Help topics and full multilingual availability, further strengthening its conversational interface to help reduce onboarding time and improve productivity.
  • Enhancements to the Arena SCI™ offering to strengthen global regulatory compliance through weekly update checks for electronic components, further supporting real-time, AI-driven component monitoring and risk mitigation with insights directly incorporated into product development workflows.

For more on Arena AI Engine, read this blog: How Arena's AI Engine Transforms Product Development Efficiency

About PTC 
PTC (NASDAQ: PTC) is a global software company that enables manufacturers and product companies to digitally transform how they design, manufacture, and service the physical products that the world relies on. Headquartered in Boston, Massachusetts, PTC employs over 7,000 people and supports more than 30,000 customers globally. For more information, please visit www.ptc.com.

Media Contact 
Greg Payne 
gpayne@ptc.com 

Investor Contact 
Matt Shimao 
mshimao@ptc.com 

PTC, Arena, Arena SCI, and the PTC logo are trademarks or registered trademarks of the PTC Inc. and its subsidiaries in the United States and other countries.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-launches-arena-ai-engine-to-accelerate-intelligent-automation-across-plm-and-qms-workflows-302636582.html

SOURCE PTC Inc.

News Provided by PR Newswire via QuoteMedia

PTC
The Conversation (0)
Stock Trend Capital

Stock Trend Capital Announces Loan to eGOD Digital Labs for Dogecoin Mining

Stock Trend Capital Inc. (CSE: PUMP) (FSE: P0G) (PTC Pink: STOCF) (the "Company" or "Stock Trend") announces that the Company has entered into a loan agreement (the "Loan Agreement") dated January 7, 2025, with 1001070426 Ontario Inc. dba eGOD Digital Labs ("eGod" or "the "Borrower"), whereby... Keep Reading...
Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy  Achieved or Maintained the Ability to Sit, Stand or Walk

Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy Achieved or Maintained the Ability to Sit, Stand or Walk

- After 5 years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected to live past 2 years of age - - 96% of Evrysdi-treated children could swallow, 80% could feed without a feeding tube and 59% could sit without support for at least 30... Keep Reading...
Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

News Summary: The new solution will combine Cisco and NVIDIA innovation to simplify the deployment of generative AI applications, providing IT visibility and analytics across the entire AI infrastructure stack. Cisco Nexus HyperFabric AI clusters make it easy for enterprise customers to build... Keep Reading...
Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

(TheNewswire) Brossard, Quebec, MAY 14, 2024 TheNewswire - Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the "Company" or "CHARBONE"), North America's only publicly traded pure-play green hydrogen company, today announced that the Company has received a US$60.8 Million... Keep Reading...
"investingnews.com"

Northstar Applies to Cross Trade on the OTCQB Venture Market in the US

Northstar Clean Technologies Inc. (TSXV: ROOF) ("Northstar" or the "Company") announces that it has filed its application for its common shares to be cross traded on the OTCQB Venture Market (the "OTCQB"). The OTCQB market provides a platform for a wide variety of companies to be able to trade... Keep Reading...
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Interactive Chart

Latest Press Releases

Related News